Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Semela

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Open Forum Infectious Diseases|August 29, 2020
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)Maroussia Roelens, Barbara Bertisch, Darius Moradpour, et al.
Hepatology (Baltimore, Md.)|December 11, 2023
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis EAli Saadat, Jérôme Gouttenoire, Paolo Ripellino, et al.
Swiss Medical Weekly|November 10, 2017
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030Philip Bruggmann, Sarah Blach, Pierre Deltenre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2021
HCV disease burden and population segments in SwitzerlandFlorian Bihl, Philip Bruggmann, Erika Castro Batänjer, et al.
Swiss Medical Weekly|December 18, 2019
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030Nicolas Goossens, Stefano Bellentani, Andreas Cerny, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 19, 2016
Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulationChristine Bernsmeier, Michael T Dill, Angela Provenzano, et al.
Swiss Medical Weekly|July 6, 2023
The current and future burden of hepatitis B in Switzerland: a modelling studyFrancesco Negro, Beat Müllhaupt, David Semela, et al.
Gastroenterology|June 10, 2006
Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinomaJuliette Martin, Fabrice Magnino, Karin Schmidt, et al.
Journal of Hepatology|December 1, 2012
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infectionMonika Rau, Felix Stickel, Stefan Russmann, et al.
Journal of Hepatology|May 14, 2013
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinomaChristian M Lange, Stéphanie Bibert, Jean-François Dufour, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Open Forum Infectious Diseases|August 29, 2020
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)Maroussia Roelens, Barbara Bertisch, Darius Moradpour, et al.
Hepatology (Baltimore, Md.)|December 11, 2023
Inborn errors of type I interferon immunity in patients with symptomatic acute hepatitis EAli Saadat, Jérôme Gouttenoire, Paolo Ripellino, et al.
Swiss Medical Weekly|November 10, 2017
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030Philip Bruggmann, Sarah Blach, Pierre Deltenre, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 28, 2021
HCV disease burden and population segments in SwitzerlandFlorian Bihl, Philip Bruggmann, Erika Castro Batänjer, et al.
Swiss Medical Weekly|December 18, 2019
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030Nicolas Goossens, Stefano Bellentani, Andreas Cerny, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 19, 2016
Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulationChristine Bernsmeier, Michael T Dill, Angela Provenzano, et al.
Swiss Medical Weekly|July 6, 2023
The current and future burden of hepatitis B in Switzerland: a modelling studyFrancesco Negro, Beat Müllhaupt, David Semela, et al.
Gastroenterology|June 10, 2006
Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinomaJuliette Martin, Fabrice Magnino, Karin Schmidt, et al.
Journal of Hepatology|December 1, 2012
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infectionMonika Rau, Felix Stickel, Stefan Russmann, et al.
Journal of Hepatology|May 14, 2013
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinomaChristian M Lange, Stéphanie Bibert, Jean-François Dufour, et al.
Pageof 10